Investors gave Marvell Technology and Lumentum a rough Monday. Within hours of announcing the largest deal either company has ever attempted, Marvell’s shares had fallen about 13% and Lumentum’s nearly 19%. The market’s verdict on a $115 billion all-stock merger was not applause.
What Marvell and Lumentum Agreed To
On November 2, 2026, the two companies said Marvell will acquire Lumentum in a deal valued at $115 billion including debt. Lumentum shareholders will receive 4.500 Marvell shares for each Lumentum share they hold. That works out to roughly $1,132 per share, a premium of about 23.9% to the October 28 closing prices, the last trading day before deal speculation began.
When the deal closes, Marvell shareholders would own about 67% of the combined company and Lumentum shareholders about 33%, on a fully diluted basis. Both boards approved the agreement unanimously. Matt Murphy stays on as Chairman and CEO, and three Lumentum directors, including CEO Michael Hurlston, would join Marvell’s seven-member board.
The timeline is long. The companies expect to finish in the first half of calendar 2028, subject to approval from both sets of stockholders, regulatory clearance and customary conditions.
Why Copper-to-Optical Is the Real Story
Marvell is best known for the electrical side of data movement. Lumentum builds the optical side. The pitch is that AI systems increasingly need both, with light replacing copper for links inside and between the machines that train and run large models. Marvell describes the combination as covering “scale-up” and “scale-in” connectivity.
The companies put a number on the prize: a combined addressable market of $550 billion. They also say they see more than $1 billion in annual run-rate cost savings, and expect the deal to add to Marvell’s non-GAAP earnings per share in the first year after closing. Those are company projections, not independent estimates.
Murphy called it, in the press release, “an opportunity that comes along once in a generation.” On CNBC’s Squawk on the Street he went further: “We are going to create a new category of company here.” Hurlston framed it from the optical side, saying Lumentum is “uniquely positioned to capitalize on a market opportunity of $550 billion.”
Lumentum Arrived With Momentum
The target is not a struggling business. On the same day as the announcement, Lumentum reported first-quarter fiscal 2027 results with revenue of $1.26 billion, up 136.5% from a year earlier. GAAP net income came in at $360.3 million, or $3.54 per diluted share. For the second quarter, the company guided to revenue between $1.575 billion and $1.625 billion, with operating margin above 45%.
Hurlston described the expected sequential growth of about $350 million as “a figure greater than the quarterly revenue of the whole company just two years ago.” That pace helps explain the price. Reports say Lumentum’s stock had climbed more than 450% over the prior year.
There is also an Nvidia connection. In March 2026, Nvidia announced a strategic partnership with Lumentum, including a $2 billion investment to expand manufacturing and research. Analysts and commentators have tied that relationship to broader scrutiny of how Nvidia backs its own suppliers, though the deal documents themselves do not address it.
Why Wall Street Flinched
The sell-off was not confined to the smaller partner. On November 3, Bank of America downgraded Marvell to Neutral from Buy and cut its price target to $225 from $400. TD Cowen moved to Hold from Buy with a target of $175, down from $350.
Bank of America analyst Vivek Arya pointed to a gap in the company’s own messaging: “There was no mention of any large M&A in MRVL’s recent analyst day.” Reporting on the firm’s concerns also cited dilution of roughly 50% in the share count against about $1 billion in cost cuts, a possible regulatory review in China, and the risk of conflicts with customers who buy from both companies.
The skepticism is not universal. UBS kept its Buy rating with a $350 target, and about 40 of 45 analysts tracked by LSEG still rate Marvell Buy or Strong Buy, according to CNBC. The downgrades are individual views, not a consensus.
A Price Tag That Moves
Because this is an all-stock deal, the headline number is a snapshot. The $115 billion and $1,132 figures were based on prices before the announcement, and both companies’ shares fell sharply afterward. The value Lumentum holders actually receive will depend on where Marvell trades when the deal closes, which is more than a year away by the companies’ own estimate.
What to Watch Next
The first formal step is a Form S-4 filing from Marvell, which will include a joint proxy statement. Stockholders of both companies will vote only after the filing is declared effective. Regulators will weigh in separately, and the possible China review flagged by Bank of America is the item most likely to shape the timetable.
Rival optical suppliers, with Coherent the most frequently mentioned by analysts, and customers who buy parts from both companies will be watching for what a merged supplier does with its pricing and bundling. Analysts have raised those possibilities, but nothing in the filings confirms them. The final test is whether AI infrastructure spending keeps climbing at the pace both companies are betting on, because a $550 billion market only exists if the buildout continues.